ArticleRadiation oncology (London, England)2026
Discerning clinical target volume of endometrial cancer via a lightweight multi-phase delineation framework.
Article in Radiation oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe accurate delineation of the clinical target volume (CTV) is a critical step in precision radiotherapy for endometrial cancer (EC). Multi-phase CT provides more information for delineating the CTV. Our study aims to establish an innovative method for the specific delineation of CTV using multi-phase CT.
methodsOur multi-phase delineation datasets comprise 175 patients who received postoperative pelvic radiotherapy. These datasets include images of contrast-enhanced computed tomography (CECT) and non-contrast-enhanced computed tomography (NECT). Additionally, we introduce a novel framework for automatically segmenting the CTV using a deep learning model. The key component of our framework is the NCLNet, which fuses features from NECT and CECT within a Lightweight Network structure. This structure is optimized using a boundary-aware multi-phase learning strategy that we propose. In addition to the dice similarity coefficient (DSC) and the average symmetric surface distance (ASSD), we propose a novel contour dice similarity coefficient (CDSC) metric to evaluate the accuracy of the predictive outer contour. Three physicians modified the predictive CTV to assess the clinical utility of the proposed method.
resultsThe NCLNet achieves a DSC of 0.871 ± 0.027 and an ASSD of 0.878 ± 0.265 mm, with lower computation complexity (5.7 M parameters and FLOPS was 639.1G). In comparison, the widely used nnUNet attains a DSC of 0.860 ± 0.027 and an ASSD of 0.920 ± 0.286 mm, while requiring significantly more parameters (31.0 M) and similar FLOPs (643.8G). The overall evaluation against several benchmarks demonstrates better or comparable performance relative to methods with higher complexity. The average modification time and the modification volume percentage of the automatically delineated CTV were only 2.9 min and 3.61%, respectively. The CDSC of 8 mm thickness was 0.853 ± 0.030, demonstrating higher correlation with the clinical modification time of experts than both DSC and ASSD.
conclusionsThe NCLNet generates high-quality automatic delineation of the CTV for postoperative pelvic radiotherapy in patients with EC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.